Each one in plain English, with the numbers worked through for a shareholder.
25 Aug 2026capital raising announcement● Neutral
Galilee lodged a cleansing prospectus offering up to 1,000 shares at A$0.0045 to raise A$4.50. It exists to lift trading restrictions on shares from the August placement, and raises no meaningful new money.
What it means for a shareholder
1,000 new shares at A$0.0045 to raise about A$5. That's 0.0000552% dilution: every existing holder's slice gets 0.0000552% smaller. If you held A$1,000 of shares (222,222 at the issue price), your slice goes from 0.0123% to 0.0123% of the company. To keep it you'd need 0 more shares - about A$0 at the issue price.
14 Aug 2026capital raising announcement● NeutralMajor
Galilee has firm commitments to raise A$3.5M via 777.8M shares at A$0.0045, each with a free listed option, to fund the Zydeco-1 sidetrack. The price is below December's A$0.007. Directors' A$135,000 needs shareholder approval.
What it means for a shareholder
778m new shares at A$0.0045 to raise about A$3.5m. That's 30% dilution: every existing holder's slice gets 30% smaller. If you held A$1,000 of shares (222,222 at the issue price), your slice goes from 0.0123% to 0.00858% of the company. To keep it you'd need 95,426 more shares - about A$429 at the issue price.
Prospectus for up to 464,285,714 new options, lodged 13 February 2026. These appear to be the free 1:2 options attached to the December placement shares (exercise A$0.011, per earlier context, an inference). Mainly a paperwork step for that raising.
Entitlement offer completed: 173.4M new shares issued at A$0.012, raising about A$2.08M, with Canaccord taking up 115.3M shares (A$1.38M) as underwriter. This meets the raising condition of the Vintage merger, which Galilee says is to be voted on later this year.
What it means for a shareholder
173m new shares at A$0.012 to raise about A$2.1m. That's 24% dilution: every existing holder's slice gets 24% smaller. If you held A$1,000 of shares (83,333 at the issue price), your slice goes from 0.015% to 0.0114% of the company. To keep it you'd need 25,934 more shares - about A$311 at the issue price.
Entitlement offer closed 13 September with valid applications for 58.1M shares (about A$700,000). The remaining 115.3M shares fall to underwriter Canaccord. Completion is expected 20 September.
Offer booklet and ineligible-shareholder letters dispatched for the 1-for-2.2 entitlement offer at A$0.012, up to 173.4M shares and about A$2.08M. Holders outside Australia and New Zealand cannot take part. Administrative step in the 15 August raising.
Offer Booklet for the underwritten 1-for-2.2 entitlement offer at A$0.012 per share, raising about A$2.08M. It is non-renounceable, so shareholders who don't take up are diluted. This implements the 15 August raising.
15 Aug 2024capital raising announcement● NeutralMajor
Galilee launched a fully underwritten raising: A$500,000 placement of about 40M shares at A$0.0125, plus a 1-for-2.2 entitlement offer for about A$2.15M at the same price. Canaccord underwrites, with about A$300,000 sub-underwritten by directors. Funds go to scheme costs and working capital. The raising is dilutive to those not taking up their entitlement.
What it means for a shareholder
40.0m new shares at A$0.0125 to raise about A$500,000. That's 11% dilution: every existing holder's slice gets 11% smaller. If you held A$1,000 of shares (80,000 at the issue price), your slice goes from 0.0235% to 0.0211% of the company. To keep it you'd need 9,419 more shares - about A$118 at the issue price.
6 June 2022capital raising announcement▲ GoodMajor
Galilee received a A$6,121,511 refundable R&D tax offset for 2020/21 from Glenaras pilot and water work. It is cash on top of the A$17.3M held at March, and the company says it was already funded for current activities.
The share purchase plan raised A$1.555M at A$0.32 for 4,859,375 new shares, well short of the A$3M target, with no scale-back. Participants get free A$0.48 options expiring 4 September 2023. Shares are issued 21 April.
What it means for a shareholder
4.9m new shares at about A$0.320 to raise about A$1.6m. That's 1.4% dilution: every existing holder's slice gets 1.4% smaller. If you held A$1,000 of shares (3,125 at the issue price), your slice goes from 0.00094% to 0.000927% of the company. To keep it you'd need 46 more shares - about A$15 at the issue price.
The share purchase plan is offered to eligible shareholders at A$0.32, up to A$30,000 each, opening 4 March and closing 4 April 2022. Participants are to get one free A$0.48 option per share, subject to a prospectus. This follows the February placement.
24 Feb 2022capital raising announcement● NeutralMajor
Galilee raised A$11.8M through a placement of 36.9M shares at A$0.32, about 11% below the last price and far below the A$0.63 raised in November 2020. Each share carries a free A$0.48 option. Funds go to five new vertical Glenaras wells. A A$3M share purchase plan and A$440,000 of director shares are planned.
What it means for a shareholder
36.9m new shares at A$0.320 to raise about A$11.8m. That's 11% dilution: every existing holder's slice gets 11% smaller. If you held A$1,000 of shares (3,125 at the issue price), your slice goes from 0.00106% to 0.00094% of the company. To keep it you'd need 390 more shares - about A$125 at the issue price.
11 Nov 2020capital raising announcement▲ GoodMajor
Galilee raised about A$15M through a placement of 23.8M shares at A$0.63, a 9.4% discount to the 5-day average price. Cash rises to about A$33M, to fund Glenaras appraisal, first-phase gas commercialisation and possible Springsure exploration. Dilutes existing holders.
What it means for a shareholder
23.8m new shares at A$0.630 to raise about A$15.0m. That's 8.1% dilution: every existing holder's slice gets 8.1% smaller. If you held A$1,000 of shares (1,587 at the issue price), your slice goes from 0.000585% to 0.000538% of the company. To keep it you'd need 139 more shares - about A$88 at the issue price.
10 Dec 2019capital raising announcement▲ GoodMajor
Option exercise raised A$16.25M at A$0.75 per share, with 97% take-up by existing holders. Canaccord's underwriting covers the remaining 750,001 shares (A$0.56M). Galilee says it is fully funded for Glenaras reserves work and Surat and Bowen exploration, resolving the December option expiry.
Canaccord agreed to underwrite exercise of the 17,900,003 options at A$0.75 expiring 5 December, subscribing for any unexercised. Galilee pays 5% of proceeds in fees. This guarantees the funds, which are for exploration in its three basins, subject to conditions.
Cleansing and dilution notice for the A$13M placement at A$0.60: 21,666,671 shares issued, 20,401,269 of them under the 7.1A capacity. Existing holders are diluted about 9.6% overall. Joint lead managers are paid 6% on about 5.5M shares placed, roughly A$3.3M (as stated).
Galilee raised about A$13M by placing 21,666,667 shares at A$0.60, with a free 1:1 option at A$0.75 expiring December 2019. A new cornerstone investor took the largest part. Funds are to secure a rig, order long-lead items and add working capital.
What it means for a shareholder
21.7m new shares at A$0.600 to raise about A$13.0m. That's 9.6% dilution: every existing holder's slice gets 9.6% smaller. If you held A$1,000 of shares (1,667 at the issue price), your slice goes from 0.000817% to 0.000739% of the company. To keep it you'd need 177 more shares - about A$106 at the issue price.
10 July 2018capital raising announcement▲ GoodMajor
Galilee raised about A$5.66M through a placement of 14.155M shares at A$0.40, a 9% premium to the 15-day VWAP, with a free 50c option expiring 31 Dec 2019 per share. Water rates reached about 2,400 barrels a day, and pressure drawdown was seen in the 11L monitoring well.
What it means for a shareholder
14.2m new shares at A$0.400 to raise about A$5.7m. That's 6.9% dilution: every existing holder's slice gets 6.9% smaller. If you held A$1,000 of shares (2,500 at the issue price), your slice goes from 0.00132% to 0.00123% of the company. To keep it you'd need 187 more shares - about A$75 at the issue price.
28 Nov 2017capital raising announcement▲ GoodMajor
The entitlement offer closed oversubscribed, raising the full A$2.59M through 17.25M shares at A$0.15; shareholders took up 59% and the rest came from shortfall applications, so underwriters placed nothing. With the placement, cash is about A$10.6M, completing the A$5.6M raising.
What it means for a shareholder
17.3m new shares at A$0.150 to raise about A$2.6m. That's 9.1% dilution: every existing holder's slice gets 9.1% smaller. If you held A$1,000 of shares (6,667 at the issue price), your slice goes from 0.00387% to 0.00351% of the company. To keep it you'd need 667 more shares - about A$100 at the issue price.
Letter to eligible shareholders restating the 1-for-10 offer at A$0.15. Shares on issue would rise to about 189.7M after the offer and placement. Underwriting fee 6%, plus 2.5M unlisted options (25c, expiring 31 Dec 2019) to Gleneagle. No new news.
Letter telling shareholders outside Australia and New Zealand they are ineligible for the rights issue, because the company judged making the offer to them unreasonable. Administrative notice repeating known offer terms.
Offer booklet for the 1-for-10 non-renounceable entitlement offer at A$0.15, raising up to about A$2.58M. Opens 9 November, closes 24 November 2017; underwritten by Patersons and Gleneagle. Detail of the raising already announced; no new news.
30 Oct 2017capital raising announcement▲ GoodMajor
Galilee is raising about A$5.6M at A$0.15 a share (9.1% discount): a A$3.05M placement of 20.3M shares plus a fully underwritten 1-for-10 entitlement offer for up to about A$2.59M. Funds go to the three-lateral Glenaras pilot and working capital.
Letter to optionholders explaining the rights issue. Options do not carry rights to participate, but holders could exercise before the 6 November record date; the letter says their options are currently out of the money. Administrative notice.
Letter to eligible Australian shareholders detailing their priority entitlement in the ERG IPO of 125m shares at 20c. The offer opens 8 November and closes 26 November. Galilee will hold just under 22% for at least two years. Repeats the 29 October terms.
What it means for a shareholder
125m new shares at A$0.200 to raise about A$25.0m. That's 45% dilution: every existing holder's slice gets 45% smaller. If you held A$1,000 of shares (5,000 at the issue price), your slice goes from 0.00329% to 0.0018% of the company. To keep it you'd need 4,108 more shares - about A$822 at the issue price.
29 Oct 2010capital raising announcement▲ GoodMajor
Prospectus lodged for a fully underwritten A$25m IPO of Eastern Resources Group: 125m shares at 20c, underwritten by Patersons. Galilee keeps at least 21.9% and has a $6.4m intercompany loan repaid. Priority offer for Galilee holders; listing targeted for 9 December.
22 July 2009capital raising announcement▲ GoodMajor
Galilee's rights issue raised about $5.48m at 6.5c; Eastern took 62.19m shares for $4.04m, funded from its own raise, lifting its stake from 67.4% to 68%. Money goes to Galilee Basin gas work including ATP 799P field work.
Confirms 2,622,549 shortfall shares allotted, leaving Eastern with 102,752,659 shares and 2,042 holders. Becamal, linked to MD Campbell Smith, remains largest holder at 18%. Administrative close of the offer.
Confirms 17,928,042 shares were allotted under the entitlement offer, trading from 17 July. Shortfall shares follow on 17 July. Administrative confirmation.
13 July 2009capital raising announcement▲ GoodMajor
Eastern's entitlement offer raised about $5m at 24c, with 87% take-up (17.9m shares). Patersons takes the 2.6m-share shortfall, with Becamal taking about half. Money funds Galilee Basin exploration.
What it means for a shareholder
17.9m new shares at about A$0.2793 to raise about A$5.0m. That's 15% dilution: every existing holder's slice gets 15% smaller. If you held A$1,000 of shares (3,580 at the issue price), your slice goes from 0.00348% to 0.00297% of the company. To keep it you'd need 624 more shares - about A$174 at the issue price.
